Polycythaemia vera (Q39428): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Policitemia vera (PV) é uma neoplasia mieloproliferativa clonal caracterizada por eritrocitose frequentemente acompanhada de leucocitose e/ou trombocitose, e um risco associado aumentado de complicações hemorrágicas e trombóticas (venoso e arterial). Mutações do exon12 JAK2 p.V617F e JAK2 (Janus quinase 2) têm sido fortemente associadas à PV. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Polycythaemia vera (PV) is a clonal myeloproliferative neoplasm characterized by erythrocytosis frequently accompanied by leukocytosis, and/or thrombocytosis, and an associated increased risk of haemorrhagic and thrombotic (venous and arterial) complications. JAK2 p.V617F and JAK2 (Janus kinase 2) exon12 mutations have been strongly associated with PV. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/818364947 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:2A20.4 | |||||||||||||||
| Property / CURIE: CID11:2A20.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-2A20.4 | |||||||||||||||
| Property / Canary Token: dki-india-2A20.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: D45 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 04:50, 13 August 2026
Polycythaemia vera (PV) is a clonal myeloproliferative neoplasm characterized by erythrocytosis frequently accompanied by leukocytosis, and/or thrombocytosis, and an associated increased risk of haemorrhagic and thrombotic (venous and arterial) complications. JAK2 p.V617F and JAK2 (Janus kinase 2) exon12 mutations have been strongly associated with PV.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A20.4 |
||
| English | Polycythaemia vera |
Polycythaemia vera (PV) is a clonal myeloproliferative neoplasm characterized by erythrocytosis frequently accompanied by leukocytosis, and/or thrombocytosis, and an associated increased risk of haemorrhagic and thrombotic (venous and arterial) complications. JAK2 p.V617F and JAK2 (Janus kinase 2) exon12 mutations have been strongly associated with PV. |
Statements
CID11:2A20.4
0 references
dki-india-2A20.4
0 references
Concluído
0 references
13 August 2026
0 references
